The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Update of a phase II, multicenter study of high-dose chemotherapy with autologous stem cell transplant followed by maintenance romidepsin for T-cell lymphoma.
 
Niloufer Khan
Research Funding - Seagen (Inst)
 
Farhad Khimani
Research Funding - Bristol-Myers Squibb (Inst)
 
Andrei R. Shustov
Consulting or Advisory Role - Kyowa Hakko Kirin; Verastem
Research Funding - Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Kyowa Hakko Kirin
 
Mazyar Shadman
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene; Cellectar; Epizyme; Genentech; Innate Pharma; Kite, a Gilead company; MorphoSys; Pharmacyclics; Sound Biologics
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); BeiGene (Inst); Bristol-Myers Squibb/Celgene; Celgene (Inst); Genentech (Inst); Merck (Inst); MustangBio (Inst); Pharmacyclics (Inst); Sunesis Pharmaceuticals (Inst); TG Therapeutics (Inst)
 
Jia Ruan
Honoraria - BMS; Kite, a Gilead company; Seagen
Consulting or Advisory Role - BMS; Cellectar; Daiichi Sankyo; Kite, a Gilead company; Seagen
Research Funding - AstraZeneca; BMS; Daiichi Sankyo; Pharmacyclics; Seagen
 
Alison J. Moskowitz
Honoraria - Seagen
Consulting or Advisory Role - ADC Therapeutics; Bristol-Myers Squibb; Imbrium Therapeutics; Janpix; Kyowa Kirin International; Merck; miRagen; Seagen; Takeda
Research Funding - ADC Therapeutics (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); miRagen (Inst); Seagen (Inst)
 
David J. Straus
Consulting or Advisory Role - Seagen; Takeda
 
Anita Kumar
Stock and Other Ownership Interests - Bridgebio
Consulting or Advisory Role - AstraZeneca/MedImmune; Celgene; Kite, a Gilead company
Research Funding - Abbvie/Genentech; Adaptive Biotechnologies; AstraZeneca/MedImmune; Celgene; Pharmacyclics; Seagen; Seagen
 
Craig Steven Sauter
Consulting or Advisory Role - Celgene/Bristol-Myers Squibb; Gamida Cell; Genmab; Genzyme; GlaxoSmithKline; Juno Therapeutics; Karyopharm Therapeutics; Kite/Gilead; Novartis; Precision Biosciences; Spectrum Pharmaceuticals
Research Funding - Bristol-Myers Squibb; Celgene/Bristol-Myers Squibb; Genzyme; Juno Therapeutics; Precision BioSciences
 
Andrew David Zelenetz
Honoraria - Clinical Care Options; NCCN; Oncology Information Group; PER; Plexus
Consulting or Advisory Role - Amgen; AstraZeneca; BeiGene; Celgene; Coherus Biosciences; Curio Science; Curis; Dava Oncology; Debiopharm Group; Genentech/Roche; Gilead Sciences; Juno/Celgene/Bristol-Myers Squibb; Karyopharm Therapeutics; Kite, a Gilead company; MEI Pharma; MorphoSys; Pharmacyclics; Quant Health; Seagen; Vaniam Group; Verastem
Research Funding - BeiGene; Genentech/Roche; Gilead Sciences; MEI Pharma
 
Ariela Noy
Consulting or Advisory Role - Janssen Biotech; MorphoSys; Prime Oncology
Research Funding - Pharmacyclics; Rafael Pharmaceuticals
Travel, Accommodations, Expenses - Janssen Oncology; Pharmacyclics
 
Gunjan L. Shah
Research Funding - Amgen; Janssen
 
Matthew J. Matasar
Stock and Other Ownership Interests - Merck
Honoraria - Bayer; Genentech; GlaxoSmithKline; IGM Biosciences; Immunovaccine; Janssen; Pharmacyclics; Roche; Seagen; Takeda
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Genentech; Juno Therapeutics; Merck; Roche; Rocket Medical; Seagen; Takeda; Teva
Research Funding - Bayer; Genentech; GlaxoSmithKline; IGM Biosciences; IGM Biosciences; Immunovaccine; Janssen; Pharmacyclics; Roche; Rocket Medical; Seagen
Travel, Accommodations, Expenses - Bayer; Genentech; Roche; Seagen
 
Pamela Drullinsky
Research Funding - Novartis (Inst)
 
Audrey M. Hamilton
No Relationships to Disclose
 
Esther N. Drill
No Relationships to Disclose
 
Koen Van Besien
No Relationships to Disclose
 
Sergio Giralt
Honoraria - Amgen; Celgene; Jazz Pharmaceuticals; Sanofi; Takeda
Consulting or Advisory Role - Actinuum; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Jazz Pharmaceuticals; Johnson & Johnson; Pfizer; Sanofi; Takeda
Research Funding - Actinuum; Amgen; Celgene (Inst); Celgene (Inst); Johnson & Johnson; Miltenyi Biotec (Inst); Sanofi; Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Sanofi
 
Steven M. Horwitz
Consulting or Advisory Role - Acrotech Biopharma; ADC Therapeutics; Astex Pharmaceuticals; C4 Therapeutics; Celgene; Janssen Oncology; Kura Oncology; Kyowa Hakko Kirin; Millennium; Myeloid Therapeutics; Ono Pharmaceutical; Portola Pharmaceuticals; Seagen; Takeda; Trillium Therapeutics; Verastem; Vividion Therapeutics
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); Aileron Therapeutics (Inst); Celgene (Inst); Corvus Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Forty Seven (Inst); Kyowa Hakko Kirin (Inst); Seagen (Inst); Takeda (Inst); Trillium Therapeutics (Inst); Verastem (Inst)
 
Parastoo Dahi
Consulting or Advisory Role - Kite/Gilead